• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活KEAP1/Nrf2信号通路的天然化合物作为治疗特发性帕金森病的潜在新药

Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.

作者信息

Huenchuguala Sandro, Segura-Aguilar Juan

机构信息

Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Santiago 8370003, Chile.

Molecular & Clinical Pharmacology, Instituto de Ciencias Biomédicas (ICBM), Faculty of Medicine, University of Chile, Santiago 8380453, Chile.

出版信息

Antioxidants (Basel). 2024 Sep 18;13(9):1125. doi: 10.3390/antiox13091125.

DOI:10.3390/antiox13091125
PMID:39334784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428591/
Abstract

Recently, a single-neuron degeneration model has been proposed to understand the development of idiopathic Parkinson's disease based on (i) the extremely slow development of the degenerative process before the onset of motor symptoms and during the progression of the disease and (ii) the fact that it is triggered by an endogenous neurotoxin that does not have an expansive character, limiting its neurotoxic effect to single neuromelanin-containing dopaminergic neurons. It has been proposed that aminochrome is the endogenous neurotoxin that triggers the neurodegenerative process in idiopathic Parkinson's disease by triggering mitochondrial dysfunction, oxidative stress, neuroinflammation, dysfunction of both lysosomal and proteasomal protein degradation, endoplasmic reticulum stress and formation of neurotoxic alpha-synuclein oligomers. Aminochrome is an endogenous neurotoxin that is rapidly reduced by flavoenzymes and/or forms adducts with proteins, which implies that it is impossible for it to have a propagative neurotoxic effect on neighboring neurons. Interestingly, the enzymes DT-diaphorase and glutathione transferase M2-2 prevent the neurotoxic effects of aminochrome. Natural compounds present in fruits, vegetables and other plant products have been shown to activate the KEAP1/Nrf2 signaling pathway by increasing the expression of antioxidant enzymes including DT-diaphorase and glutathione transferase. This review analyzes the possibility of searching for natural compounds that increase the expression of DT-diaphorase and glutathione transferase through activation of the KEAP1/Nrf2 signaling pathway.

摘要

最近,基于以下两点提出了一种单神经元退化模型来理解特发性帕金森病的发展过程:(i)在运动症状出现之前以及疾病进展过程中,退化过程发展极其缓慢;(ii)该疾病由一种不具有扩散特性的内源性神经毒素引发,其神经毒性作用仅限于单个含神经黑色素的多巴胺能神经元。有人提出氨基色素是引发特发性帕金森病神经退行性过程的内源性神经毒素,它通过引发线粒体功能障碍、氧化应激、神经炎症、溶酶体和蛋白酶体蛋白质降解功能障碍、内质网应激以及神经毒性α-突触核蛋白寡聚体的形成来实现。氨基色素是一种内源性神经毒素,可被黄素酶迅速还原和/或与蛋白质形成加合物,这意味着它不可能对邻近神经元产生传播性神经毒性作用。有趣的是,DT-黄递酶和谷胱甘肽转移酶M2-2可预防氨基色素的神经毒性作用。水果、蔬菜和其他植物产品中存在的天然化合物已被证明可通过增加包括DT-黄递酶和谷胱甘肽转移酶在内的抗氧化酶的表达来激活KEAP1/Nrf2信号通路。本综述分析了寻找通过激活KEAP1/Nrf2信号通路来增加DT-黄递酶和谷胱甘肽转移酶表达的天然化合物的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d523/11428591/384ce5cc80dd/antioxidants-13-01125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d523/11428591/bf51f1e02e36/antioxidants-13-01125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d523/11428591/384ce5cc80dd/antioxidants-13-01125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d523/11428591/bf51f1e02e36/antioxidants-13-01125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d523/11428591/384ce5cc80dd/antioxidants-13-01125-g002.jpg

相似文献

1
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.激活KEAP1/Nrf2信号通路的天然化合物作为治疗特发性帕金森病的潜在新药
Antioxidants (Basel). 2024 Sep 18;13(9):1125. doi: 10.3390/antiox13091125.
2
Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.单神经元神经退行性变作为帕金森病的一种退行性模型。
Neural Regen Res. 2024 Mar;19(3):529-535. doi: 10.4103/1673-5374.380878.
3
Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase.针对氨基色素神经毒性的神经保护作用:谷胱甘肽转移酶M2-2和DT-黄递酶
Antioxidants (Basel). 2022 Jan 31;11(2):296. doi: 10.3390/antiox11020296.
4
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.一种基于通过KEAP1/NRF2激活转录基因来开发新的抗氧化疗法的帕金森病临床前模型。
Antioxidants (Basel). 2023 Mar 9;12(3):673. doi: 10.3390/antiox12030673.
5
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model.根据单神经元退化模型寻找特发性帕金森病新的药物治疗靶点。
Biomolecules. 2024 Jun 8;14(6):673. doi: 10.3390/biom14060673.
6
Protective and toxic roles of dopamine in Parkinson's disease.多巴胺在帕金森病中的保护和毒性作用。
J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18.
7
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease.内源性神经毒素与神经保护在帕金森病中的作用
Neural Regen Res. 2017 Jun;12(6):897-901. doi: 10.4103/1673-5374.208560.
8
Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.氨基色素作为研究帕金森病中多巴胺能神经元变性的临床前实验模型。
Neurotox Res. 2007 Sep;12(2):125-34. doi: 10.1007/BF03033921.
9
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?多巴胺氧化代谢产物是否参与帕金森病黑质纹状体系统中多巴胺能神经元的丧失?
ACS Chem Neurosci. 2017 Apr 19;8(4):702-711. doi: 10.1021/acschemneuro.7b00034. Epub 2017 Mar 3.
10
Molecular and neurochemical mechanisms in PD pathogenesis.PD 发病机制中的分子和神经化学机制。
Neurotox Res. 2009 Oct;16(3):271-9. doi: 10.1007/s12640-009-9059-4. Epub 2009 May 20.

引用本文的文献

1
Cannabidiol Extracted from L. Plant Shows Neuroprotective Impacts Against 6-HODA-Induced Neurotoxicity via Signal Transduction Pathway.从L.植物中提取的大麻二酚通过信号转导途径对6-羟基多巴胺诱导的神经毒性具有神经保护作用。
Iran J Pharm Res. 2025 May 26;24(1):e160499. doi: 10.5812/ijpr-160499. eCollection 2025 Jan-Dec.

本文引用的文献

1
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model.根据单神经元退化模型寻找特发性帕金森病新的药物治疗靶点。
Biomolecules. 2024 Jun 8;14(6):673. doi: 10.3390/biom14060673.
2
Physalin H ameliorates LPS-induced acute lung injury via KEAP1/NRF2 axis.原黄素 H 通过 KEAP1/NRF2 轴减轻 LPS 诱导的急性肺损伤。
Int Immunopharmacol. 2024 Apr 20;131:111789. doi: 10.1016/j.intimp.2024.111789. Epub 2024 Mar 13.
3
Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation.
芒柄花素,一种来自黄芪(膜荚黄芪)的生物活性异黄酮成分,通过激活 Keap1/Nrf2 信号通路改善 1 型糖尿病:网络药理学和实验验证支持的综合研究。
J Ethnopharmacol. 2024 Mar 25;322:117576. doi: 10.1016/j.jep.2023.117576. Epub 2023 Dec 15.
4
α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis.α-突触核蛋白的传播通过小胶质细胞吞噬突触导致皮层突触异常。
Mol Brain. 2023 Oct 17;16(1):72. doi: 10.1186/s13041-023-01059-1.
5
Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.单神经元神经退行性变作为帕金森病的一种退行性模型。
Neural Regen Res. 2024 Mar;19(3):529-535. doi: 10.4103/1673-5374.380878.
6
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies.α-突触核蛋白寡聚体和原纤维:突触核蛋白病中的“共犯”
Neural Regen Res. 2023 Nov;18(11):2332-2342. doi: 10.4103/1673-5374.371345.
7
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.传播性 α-突触核蛋白种子作为突触核蛋白病的血清生物标志物。
Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. Epub 2023 May 29.
8
Grape seed meal by-product is able to counteract oxidative stress induced by lipopolysaccharide and dextran sulphate in IPEC cells and piglets after weaning.葡萄籽粕副产物能够抵抗脂多糖和葡聚糖硫酸钠诱导的 IPEC 细胞和断奶仔猪的氧化应激。
PLoS One. 2023 Apr 13;18(4):e0283607. doi: 10.1371/journal.pone.0283607. eCollection 2023.
9
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.一种基于通过KEAP1/NRF2激活转录基因来开发新的抗氧化疗法的帕金森病临床前模型。
Antioxidants (Basel). 2023 Mar 9;12(3):673. doi: 10.3390/antiox12030673.
10
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease.DOPAL引发帕金森病中α-突触核蛋白依赖性的蛋白稳态受损和神经元突起退化。
NPJ Parkinsons Dis. 2023 Mar 25;9(1):42. doi: 10.1038/s41531-023-00485-1.